PHS
OM icon

PFM Health Sciences’s Outset Medical OM Stock Holding History

PFM Health Sciences’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.51M Sell
582,122
-12,508
-2% -$54.7K 0.22% 86
2026
Q1 		$2.28M Buy
594,630
+63,834
+12% +$262K 0.21% 75
2025
Q4 		$1.97M Sell
530,796
-1,199,125
-69% -$10.3M 0.2% 69
2025
Q3 		$24.4M Buy
1,729,921
+65,194
+4% +$1.02M 1.88% 15
2025
Q2 		$32M Sell
1,664,727
-21,000
-1% -$328K 2.72% 10
2025
Q1 		$18.6M Buy
+1,685,727
New +$20.1M 1.35% 27
2024
Q3 		– Sell
-49,640
Closed -$2.87M – 83
2024
Q2 		$2.87M Sell
49,640
-28,229
-36% -$1.38M 0.14% 63
2024
Q1 		$2.59M Buy
77,869
+11,252
+17% +$570K 0.12% 79
2023
Q4 		$5.41M Buy
+66,617
New +$5.42M 0.32% 52
2023
Q2 		– Sell
-21,665
Closed -$5.98M – 90
2023
Q1 		$5.98M Buy
+21,665
New +$7.95M 0.26% 64
2022
Q4 		– Sell
-48,628
Closed -$11.6M – 95
2022
Q3 		$11.6M Buy
+48,628
New +$13M 0.42% 61
2022
Q2 		– Sell
-187,379
Closed -$128M – 87
2022
Q1 		$128M Sell
187,379
-8,638
-4% -$5.2M 4.77% 1
2021
Q4 		$136M Sell
196,017
-1,764
-0.9% -$1.3M 4.61% 2
2021
Q3 		$147M Hold
197,781
– – 4.31% 2
2021
Q2 		$148M Sell
197,781
-3,066
-2% -$2.34M 4.65% 3
2021
Q1 		$164M Buy
200,847
+6,767
+3% +$5.22M 5% 2
2020
Q4 		$151M Buy
194,080
+2,547
+1% +$1.96M 5.3% 2
2020
Q3 		$131M Buy
+191,533
New +$157M 6.04% 1

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

PFM Health Sciences's OM Position: Q2 2026 in Review

PFM Health Sciences reduced its Outset Medical (OM) stake by 2.1% in Q2 2026, selling an estimated $54.7K and leaving 582,122 shares worth $2.51M. The position accounts for 0.22% of the portfolio, ranked #86.

PFM Health Sciences first reported a position in OM in Q3 2020 and has held it in 18 quarters since. The position peaked at $164M in Q1 2021. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • PFM Health Sciences held 582,122 shares of Outset Medical worth $2.51M as of Q2 2026.
  • PFM Health Sciences sold 12,508 Outset Medical shares in Q2 2026, an estimated $54.7K.
  • Outset Medical made up 0.22% of PFM Health Sciences's portfolio in Q2 2026, its #86 holding.
  • PFM Health Sciences first reported a position in Outset Medical in Q3 2020 and has held it in 18 quarters since.
  • PFM Health Sciences's Outset Medical position peaked at $164M in Q1 2021.
  • 93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.